Our Pricing

Buy Wegovy Online UK: Private Prescription Route

Published on: June 03, 2026

If you're looking to buy Wegovy online UK private prescription, Cured Pharmacy offers a streamlined clinical pathway with transparent pricing from £79.00, UK-registered prescribers, and discreet next-day delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every patient receives genuine UK-licensed semaglutide with comprehensive clinical oversight.

How to Buy Wegovy Online UK: The Private Prescription Process

The private prescription route for Wegovy in the UK involves three regulated steps: online clinical assessment, prescriber review, and pharmacy dispensing. At Cured Pharmacy, our UK-registered clinical team completes your free consultation in under 3 minutes, assessing your medical history, current medications, and weight management goals [1].

Once approved by a UK prescriber, your Wegovy prescription is sent electronically to our GPhC-registered pharmacy (9012511). We dispense only genuine UK-licensed semaglutide pens, manufactured to MHRA standards, and dispatch in 100% discreet packaging with tracked delivery [2].

Unlike NHS pathways where Wegovy availability may be restricted by local formularies, the private prescription route provides consistent access subject to clinical suitability. Your prescriber will determine the appropriate starting dose based on your individual assessment, typically beginning with the 0.25mg weekly dose as per NICE guidance [3].

Who Can Access Private Wegovy Prescriptions?

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your UK prescriber will verify eligibility during the online consultation, reviewing contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Wegovy Clinical Evidence: STEP Trial Results

Wegovy contains semaglutide 2.4mg, the highest licensed dose of this GLP-1 receptor agonist for chronic weight management. In the landmark STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks when combined with lifestyle intervention, compared to 2.4% with placebo [1].

The STEP 3 trial, which incorporated intensive behavioural therapy alongside Wegovy, demonstrated even greater outcomes with average weight loss of 16% at 68 weeks [4]. Importantly, 86.4% of participants in the semaglutide group achieved at least 5% weight loss, meeting the clinical threshold for meaningful health benefits including improved cardiovascular risk markers [1][4].

Semaglutide works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and food intake. By activating GLP-1 receptors in the brain, Wegovy reduces hunger signals and increases satiety, making it easier to maintain a reduced-calorie diet without the intense cravings that often derail weight management efforts [2].

Wegovy Dosing Schedule and Titration

Wegovy follows a structured 16-week dose escalation schedule designed to minimise gastrointestinal side effects while optimising therapeutic response. The standard titration begins at 0.25mg weekly for 4 weeks, increasing to 0.5mg, then 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [3].

This gradual escalation allows your body to adapt to semaglutide's effects on gastric emptying and appetite regulation. Clinical trials showed that patients who followed the prescribed titration schedule experienced significantly fewer treatment discontinuations due to nausea or vomiting compared to faster dose increases [1].

Each Wegovy pen contains four pre-filled doses for one month of treatment. Your UK prescriber will issue prescriptions aligned with your current dose stage, ensuring you progress safely through the titration schedule. If you experience persistent side effects at any dose level, your prescriber may extend that dose phase before escalating further, a flexibility that private prescription pathways readily accommodate [3].

Managing Missed Doses

If you miss a Wegovy dose and the next scheduled dose is more than 2 days away, take the missed dose as soon as possible. If less than 2 days remain until your next dose, skip the missed dose and resume your regular schedule. Never double doses to compensate for missed injections, as this significantly increases the risk of gastrointestinal side effects [3].

Wegovy Side Effects and Safety Monitoring

The most commonly reported side effects of Wegovy are gastrointestinal, including nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are typically mild to moderate, most pronounced during dose escalation phases, and tend to diminish as treatment continues.

Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent glucose-lowering medications. The STEP trials reported acute pancreatitis in 0.2% of semaglutide-treated participants versus 0% with placebo [1]. Your UK prescriber will assess your pancreatic and gallbladder history before prescribing Wegovy.

Regular monitoring is essential during Wegovy treatment. Your prescriber may recommend follow-up consultations at 4-week intervals during titration, then quarterly once you reach the maintenance dose. This allows for early detection of adverse effects, assessment of weight loss progress, and adjustment of concurrent medications as your metabolic profile improves [3].

Wegovy Price UK: Understanding Private Prescription Costs

At Cured Pharmacy, Wegovy is priced from £79.00 per month, representing competitive UK pricing with transparent costs displayed before you begin your consultation. This upfront pricing model eliminates the hidden fees or post-consultation price increases that some patients encounter elsewhere.

The monthly cost covers your supply of four pre-filled Wegovy pens, UK prescriber consultation, and discreet home delivery. As you progress through the dose escalation schedule, your prescriber will issue prescriptions for the appropriate strength, with pricing remaining consistent across dose levels to support treatment continuity.

Private prescription costs for weight management medications reflect the comprehensive clinical service, pharmaceutical supply chain, and regulatory compliance required for prescription-only medicines. Cured Pharmacy's lowest prices guaranteed commitment means if you find genuine UK-licensed Wegovy at a lower price from another UK-registered pharmacy, we'll match it. Our GPhC registration (9012511) ensures you receive authentic medications dispensed to the highest professional standards.

What's Included in Your Wegovy Prescription

Your monthly Wegovy supply includes four single-use pre-filled pens, each delivering one weekly dose. The pen device features a simple click mechanism that doesn't require dose selection, reducing the risk of administration errors. All pens are supplied in temperature-controlled packaging to maintain semaglutide stability during transit, with clear storage instructions provided.

Wegovy vs Other Weight Loss Treatments Available in the UK

Wegovy is one of several prescription weight management options licensed in the UK, each with distinct mechanisms, dosing schedules, and clinical evidence profiles. Understanding these differences helps you and your prescriber select the most appropriate treatment for your individual circumstances.

Saxenda (liraglutide 3mg) is another GLP-1 receptor agonist, but requires daily subcutaneous injection rather than Wegovy's weekly schedule. In head-to-head comparisons, semaglutide 2.4mg demonstrated superior weight loss outcomes, with the STEP 8 trial showing 15.8% average weight reduction with Wegovy versus 6.4% with Saxenda over 68 weeks [5].

Orlistat, available both on prescription and over-the-counter at lower doses, works by blocking dietary fat absorption rather than modulating appetite hormones. While orlistat may suit patients who prefer oral medication, clinical trials show more modest weight loss averaging 3-5% compared to semaglutide's 15% average reduction [1][6]. Your UK prescriber will discuss these options during your consultation, considering your medical history, lifestyle factors, and treatment preferences.

Combination Approaches and Lifestyle Modification

Wegovy is licensed as an adjunct to reduced-calorie diet and increased physical activity, not as monotherapy. The STEP trials incorporated structured lifestyle interventions including dietary counselling and exercise programmes, demonstrating that combined approaches produce optimal outcomes [1]. Your prescriber may recommend referral to registered dietitians or exercise specialists to maximise your treatment response and develop sustainable habits beyond medication use.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Wegovy 2.4 mg solution for injection in pre-filled pen. GOV.UK. [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA875]. [accessed 13 August 2026]
4. Wadden, T. A., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831 [accessed 13 August 2026]
5. Rubino, D. M., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
6. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.